image
Amicus Therapeutics, Inc. FOLD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
INCOME STATEMENT
528 M REVENUE
32.29%
Growth Rates
1Year 32.29%
3Years 20.03%
5Years 23.72%
7Years 46.24%
10Years 83.45%
24.9 M OPERATING INCOME
133.85%
Growth Rates
1Year 133.85%
3Years 28.55%
5Years 15.80%
7Years 10.85%
10Years 8.98%
-56.1 M NET INCOME
62.99%
Growth Rates
1Year 62.99%
3Years 39.27%
5Years 30.91%
7Years 20.68%
10Years 2.04%
EFFICIENCY
Earnings Waterfall Amicus Therapeutics, Inc.
image
Revenue 528 M
Cost Of Revenue 52.9 M
Gross Profit 475 M
Operating Expenses 450 M
Operating Income 24.9 M
Other Expenses 81 M
Net Income -56.1 M

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003
REVENUE
Revenue 528.3 399.4 329.2 305.5 260.9 182.2 91.2 36.9 5.0 0 1.2 0.4 18.4 21.4 0.9 64.4 15.0 1.8 0 0 0 0
GROSS PROFIT
Cost Of Revenue 52.9 37.3 38.6 34.5 31.0 22.0 14.4 6.2 0.8 1.8 0 13.5 20.4 0 0 0 0 0 0 0 0 0
Gross Profit 475.4 362.0 290.6 271.0 229.8 160.3 76.8 30.7 4.1 (1.8) 1.2 (13.1) (2.0) 21.4 0.9 64.4 15.0 1.8 0 0 0 0
OPERATING INCOME
Operating Expenses 450.5 427.7 495.1 471.0 473.7 461.0 402.3 241.6 179.2 126.0 69.9 62.6 71.3 72.3 56.8 70.2 58.9 47.6 46.9 20.8 (8.8) 6.6
Selling, General and Administrative Expenses 323.4 275.3 213.0 192.7 156.4 169.9 127.2 88.7 71.2 47.3 20.7 18.9 19.4 19.9 15.7 20.0 19.7 15.3 12.3 6.9 0 0
Research and Development Expenses 109.4 152.4 276.7 272.0 308.4 286.4 270.9 149.3 104.8 76.9 47.6 41.9 50.3 50.9 39.0 48.1 37.8 31.1 33.6 13.7 0 4.4
Operating Income 24.9 (73.5) (204.4) (199.9) (243.9) (300.7) (328.8) (442.0) (181.9) (130.4) (68.7) (64.2) (52.9) (50.9) (55.8) (7.3) (44.0) (45.8) (46.9) (20.8) (8.8) (6.6)
PRE-TAX INCOME
Interest Income Expense 49.6 50.1 37.1 32.5 22.4 18.9 22.4 17.2 5.4 1.6 1.5 46 K 89 K 0.1 0.3 0.3 0.2 0 0 0 0 0
Total Other Income (53.6) (76.6) (37.6) (41.6) (30.4) (55.2) (23.6) (7.1) (21.9) (6.1) (1.3) 1.0 0.9 2.8 (0.2) 0.8 4.6 4.6 0.5 0.2 0 (0.2)
Pre-Tax Income (28.8) (150.1) (242.0) (241.6) (274.3) (355.9) (349.1) (449.1) (203.8) (132.1) (70.0) (63.1) (52.0) (48.0) (56.1) (6.6) (39.4) (41.2) (46.3) (20.6) 0 (6.8)
NET INCOME
Tax Provision 27.4 1.5 (5.5) 8.9 2.6 0.5 94 K (165.1) (3.7) 1.5 (1.1) (3.5) (3.2) (3.6) (1.1) 0.3 0 0.4 (0.5) (0.6) 8.8 0
Net Income (56.1) (151.6) (236.6) (250.5) (276.9) (356.4) (349.0) (284.0) (200.0) (132.1) (68.9) (59.6) (48.8) (44.4) (54.9) (6.6) (39.4) (41.2) (46.3) (20.0) (8.8) (6.8)
EPS 0.18 0.51 0.82 0.92 1.07 1.48 1.88 1.85 1.49 1.2 0.93 1.16 1.07 1.28 1.98 0.29 1.75 3.11 63 48.7 28.6 22